Annual SGA
$24.61 M
+$1.77 M+7.76%
December 1, 2023
Summary
- As of February 22, 2025, MAZE annual SGA is $24.61 million, with the most recent change of +$1.77 million (+7.76%) on December 1, 2023.
- During the last 3 years, MAZE annual SGA has risen by +$1.77 million (+7.76%).
Performance
MAZE SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$6.87 M
NaN%
September 1, 2024
Summary
- As of February 22, 2025, MAZE quarterly SGA is $6.87 million
Performance
MAZE Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$998.69 M
-$313.88 M-45.83%
September 1, 2024
Summary
- As of February 22, 2025, MAZE TTM SGA is -$998.69 million, with the most recent change of -$313.88 million (-45.83%) on September 1, 2024.
Performance
MAZE TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MAZE Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.8% | - | - |
| 3 y3 years | +7.8% | - | - |
| 5 y5 years | +7.8% | - | - |
MAZE Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -7.2% | -1.9% | -16.0% | +152.4% | at low |
| 5 y | 5-year | at high | -7.2% | -1.9% | -16.0% | +152.4% | at low |
| alltime | all time | at high | -7.2% | -1.9% | -16.0% | +152.4% | at low |
Maze Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.87 M(-1.9%) | $13.88 M(+8.6%) |
| Dec 2023 | $24.61 M | $7.01 M(+21.4%) | $12.78 M(+121.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $5.77 M | $5.77 M |
| Dec 2022 | $22.83 M | - | - |
FAQ
- What is Maze Therapeutics annual SGA?
- What is the all time high annual SGA for Maze Therapeutics?
- What is Maze Therapeutics annual SGA year-on-year change?
- What is Maze Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Maze Therapeutics?
- What is Maze Therapeutics TTM SGA?
- What is the all time high TTM SGA for Maze Therapeutics?
What is Maze Therapeutics annual SGA?
The current annual SGA of MAZE is $24.61 M
What is the all time high annual SGA for Maze Therapeutics?
Maze Therapeutics all-time high annual SGA is $24.61 M
What is Maze Therapeutics annual SGA year-on-year change?
Over the past year, MAZE annual SGA has changed by +$1.77 M (+7.76%)
What is Maze Therapeutics quarterly SGA?
The current quarterly SGA of MAZE is $6.87 M
What is the all time high quarterly SGA for Maze Therapeutics?
Maze Therapeutics all-time high quarterly SGA is $7.01 M
What is Maze Therapeutics TTM SGA?
The current TTM SGA of MAZE is -$998.69 M
What is the all time high TTM SGA for Maze Therapeutics?
Maze Therapeutics all-time high TTM SGA is -$395.69 M